Publications

Treatment of IL-18-binding protein biologics suppresses fibrotic progression in metabolic dysfunction-associated steatohepatitis

 110
Treatment of IL-18-binding protein biologics suppresses fibrotic progression in metabolic dysfunction-associated steatohepatitis

Tags:

Previous Article

Post Translation Modification

Next Article

Treatment of IL-18-binding protein biologics to treat liver disease

Related Posts

Age-related constraints on the spatial geometry of the brain

Age-related constraints on the spatial geometry of the ...

 31

Altered sphingolipid biosynthetic flux and lipoprotein trafficking contribute to trans-fat-induced atherosclerosis

Altered sphingolipid biosynthetic flux and lipoprotein ...

 82

Vitamin D and major chronic diseases

Vitamin D and major chronic diseases

 126